Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01594658
Other study ID # VUT-3F
Secondary ID
Status Completed
Phase N/A
First received July 18, 2011
Last updated September 30, 2012
Start date July 2011
Est. completion date September 2012

Study information

Verified date September 2012
Source Hospital Occidente de Kennedy
Contact n/a
Is FDA regulated No
Health authority Colombia: Institutional Review Board
Study type Observational

Clinical Trial Summary

The venous ulcer due to venous insufficiency causes an important morbility to those people suffering from this condition. Most of therapies available under the obligatory health plan (POS, acronym in spanish) to date cover the cleaning of the ulcerous lesion and its medical handling using saline solutions, topical antibiotics and elastic dressings, implying an important intake from health resources due to its chronicity and the delay in ulcers healing, which usually takes periods ranging from 6 months to several years. therapeutical alternatives, which can guarantee optimal, fast and persistent in time healings, should be identified.

The aim of this study is to determine the percentage of healing of active venous ulcers (using a clinical, etiological, anatomic and physiopathologic classification (CEAP), C6) following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration after six months from the intervention, compared with conservative medical handling. The investigators expect that the ultrasound-guided foam sclerotherapy of superficial venous reflux will diminish the time of ulcer healing compared with standard handling.


Description:

to determine healing rates following ultrasound-guided foam sclerotherapy (UGFS) of superficial venous reflux (SVR) in patients with open (clinical,etiologic, anatomic and pathophysiologic (CEAP) classification, C6) chronic venous ulceration ( CVU) in a randomised clinical trial of foam sclerotherapy for patients with venous ulcer


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date September 2012
Est. primary completion date February 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Presence of Venous Ulcer confirmed by CEAP C6

- Chronic venous ulcer present for at least 4 weeks

- Ankle-arm index greater or equal to 0.8 mmHg

Exclusion Criteria:

- Severe hepatic, cardiac or pulmonary disease

- Deep venous thrombosis

- Active participation in other clinical trials

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Foam sclerotherapy
Foam application of 1% (Sklerol®, ICV Pharma, Bogota-Colombia), Reg INVIMA: 2002M-0001016, guided by ecography of insufficient superficial veins, doses from 10-40 cc of foam until obtaining endoluminal occlusion of the vein. The patient will rest for 8 minutes and then the leg will be covered with elastic bandage.
conservative
This arm only has medical standard handling (healings performed by the nurse group)

Locations

Country Name City State
Colombia Hospital Occidente de Kennedy Bogota Cundinamarca

Sponsors (2)

Lead Sponsor Collaborator
Hospital Occidente de Kennedy Universidad El Bosque, Bogotá

Country where clinical trial is conducted

Colombia, 

References & Publications (2)

Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW. Ultrasound-guided foam sclerotherapy for the treatment of chronic venous ulceration: a preliminary study. Eur J Vasc Endovasc Surg. 2009 Dec;38(6):764-9. doi: 10.1016/j.ejvs.2009.05.027. Epub 2009 Jul 18. — View Citation

Pang KH, Bate GR, Darvall KA, Adam DJ, Bradbury AW. Healing and recurrence rates following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration. Eur J Vasc Endovasc Surg. 2010 Dec;40(6):790-5. doi: 10.1016/j.ejvs.2010.08.011. Epub 2010 Sep 27. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Venous Ulcer Treatment with Foam Versus Conservative Treatment Number of participants with healing of venous ulcer after six months from the intervention. 6 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Recruiting NCT02838784 - Efficacy and Safety of Artacentâ„¢ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers N/A
Completed NCT02092870 - Adipose Derived Regenerative Cellular Therapy of Chronic Wounds Phase 2
Terminated NCT00847002 - Flexitouch Treatment for Venous Ulcers N/A
Completed NCT01858272 - Preliminary Testing of New Treatment for Chronic Leg Wounds Phase 1
Not yet recruiting NCT05877378 - Efficacy of PICO Single-use System in Chronic Ulcers N/A
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Terminated NCT01396304 - Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers Phase 4
Not yet recruiting NCT06007703 - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Completed NCT04046120 - Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers N/A
Terminated NCT04021316 - Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration N/A
Completed NCT05729334 - Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions N/A
Completed NCT03070938 - PuraPlyâ„¢ Antimicrobial Wound Matrix and Wound Management N/A
Terminated NCT01853384 - Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers Phase 3
Completed NCT00558662 - Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers N/A
Completed NCT01750749 - Cell Therapy for Venous Leg Ulcers Pilot Study Phase 1
Completed NCT01327937 - A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers Phase 4
Completed NCT00820196 - A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study) Phase 2
Completed NCT00301496 - Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers N/A
Recruiting NCT05489588 - The GORE® VIAFORT Vascular Stent Iliofemoral Study N/A

External Links